Cytokinetics Inc. (CYTK) Dividend History

Company News

• Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

  Cytokinetics, a biopharmaceutical company, announced that it granted stock options and restricted stock units to 11 new employees as a material inducement to their employment. The awards are subject to the company's equity incentive plan and vesting schedules.

  GlobeNewswire Inc.
• FDA Pushes Potential Approval For Cytokinetics' Experimental Heart Drug By Three Months

  The FDA has extended the PDUFA action date for Cytokinetics' new drug application for aficamten, an experimental heart drug, by three months to allow for a full review of the company's proposed Risk Evaluation and Mitigation Strategy (REMS).

  Benzinga

  Featured Companies: BMY
• Why Cytokinetics (CYTK) Stock Price Was Down 17% on Thursday

  Cytokinetics (CYTK) declines after announcing plans for raising about a billion dollars in funding.

  Zacks Investment Research

  Featured Companies: BMY RPRX
• 2 Incredible Growth Stocks to Buy Right Now

  These two biotech stocks could be big winners in the years ahead.

  The Motley Fool

  Featured Companies: VKTX
• This biotech ETF sees ‘breakout’ while U.S. small-cap technology stocks lag

  This week’s ETF Wrap digs into the jump in biotech funds, as well as an “unusual” trend in U.S. small-cap stocks versus small-cap tech equities.

  MarketWatch

  Featured Companies: AMGN ARKB BBC BITB EWW FBTC FNDE GBTC IBB IBIT IJR IOVA MBSF MCHI MSOS NRES PPLT PSCT REGN SBIO VKTX VRTX XBI XLK XRT